EMTT / Magnetic Therapy
High-energy electromagnetic fields to modulate inflammation, influence cellular signalling and support tissue healing.
What EMTT / magnetic therapy is
EMTT stands for Extracorporeal Magnetotransduction Therapy. It is a non-invasive treatment that delivers high-energy pulsed electromagnetic fields into tissue. It sits within a broader family of electromagnetic therapies, typically as a higher-energy, short-duration treatment intended to influence biological signalling in musculoskeletal tissues.
It is most often discussed in relation to pain modulation, tissue recovery support, bone healing support, chronic overload or degenerative presentations, and adjunctive use alongside other treatments.
In plain English
EMTT is not a surgical treatment, and it is not the same as shockwave. Shockwave uses acoustic energy; EMTT uses electromagnetic energy.
How EMTT may work
The mechanistic rationale for EMTT is plausible, but the clinical evidence base is still developing.
Influence on cellular signalling — preclinical work suggests effects on cellular activity involved in repair and regeneration.
Potential effects on tendon biology — early experimental work reported effects on tenocyte proliferation, migration and matrix production. This is early-stage evidence and should not be overstated clinically.
Pain and inflammatory modulation — broader magnetic-field literature suggests possible analgesic and anti-inflammatory effects, but mechanism and consistency remain incompletely defined.
In plain English
The most honest way to describe EMTT: it may help create a more favourable biological environment in selected tissues, but the clinical evidence is still emerging and is not as strong or mature as the evidence for shockwave in tendinopathy.
What the evidence currently looks like
The EMTT evidence base is still early. Preclinical and laboratory data suggest possible biological effects on bone-forming cells and tenocytes, and pilot and early clinical reports suggest it may be useful as an adjunct in selected recovery settings. However, there are not yet large, high-quality, condition-specific clinical trials across the common musculoskeletal indications, and broader PEMF literature is mixed.
Practical conclusion
EMTT should currently be presented as an adjunctive treatment, used selectively, within a broader pathway — not as a stand-alone solution, and not as a therapy with a uniformly strong evidence base across all musculoskeletal problems.
Who EMTT may suit
EMTT may be considered in selected patients with persistent overload-related pain, degenerative joint patterns, peri-articular or soft-tissue irritability, recovery plateaus, selected bone-healing or post-procedural contexts, and cases where a broader multimodal pathway is being used.
At present, the strongest justification for EMTT is usually as a supportive adjunct, not as the centrepiece of treatment.
What EMTT can and cannot do
What EMTT may do
Support a more favourable tissue environment
Reduce irritability in selected cases
Fit alongside rehabilitation and other treatments
Contribute to a broader multimodal recovery strategy
What EMTT cannot do
Act as a stand-alone cure
Replace good diagnosis
Replace rehab, strengthening or load management
Work for every painful tissue
Be sold as a miracle technology
The strongest way to describe EMTT is as a selective adjunct with emerging evidence, not a replacement for more established treatment pathways.
Where EMTT fits in a broader pathway
EMTT is most useful when it has a clear job to do. In selected joint preservation cases the pathway may combine rehabilitation and movement strategy, orthobiologics where appropriate, HA or PRP in selected settings, Arthrosamid in suitable knees, shockwave where tendon or peri-articular overload is contributing, and EMTT as an adjunctive biological support modality. The point is not to stack technologies for the sake of it, but to use each tool where it serves a clinically defensible purpose.
Safety and aftercare basics
EMTT is non-invasive and generally well tolerated.
Typical short-term features
Little to no downtime
Minimal discomfort during treatment
Gradual rather than immediate effects
Basic principles
It should sit within a larger plan
It should not distract from rehabilitation and progression
Outcomes should be judged in terms of function, not simply sensation
Frequently asked questions
Is EMTT evidence-based?
There is emerging evidence and mechanistic rationale, especially from preclinical work and early pilot studies, but the evidence base is still developing and is not as strong as the shockwave literature in chronic tendinopathy.
Is EMTT the same as PEMF?
Not exactly. EMTT sits within the broader electromagnetic therapy family, but specific EMTT devices and protocols are distinct. Some background evidence is extrapolated from PEMF studies, which is one reason claims should remain cautious.
Is EMTT the same as shockwave?
No. Shockwave uses acoustic energy; EMTT uses electromagnetic energy.
Is EMTT the same as laser therapy?
No. Laser uses light energy; EMTT uses electromagnetic pulses.
Can EMTT be combined with shockwave?
Yes, in selected cases within a broader multimodal plan, but only when each modality has a clear role and the diagnosis supports it.
Is EMTT enough on its own?
Usually no. It is best used as an adjunct within a structured treatment strategy.